Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Intellia Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 295
- +21 vs. Q3 2025
- Shares held
- 104.3M
- +271.3K (+0.3%) vs. Q3 2025
- Total value
- $938.9M
- −$856.7M (−47.7%) vs. Q3 2025
- New holders
- 68
- 98 more added
- Sold out
- 47
- 87 more reduced
10 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Trexquant Investment LP | 0 | $0 | 0.00% | −270,115−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −255,555−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −174,261−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −147,300−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −137,290−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −74,266−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −63,509−100.0% | Sold out |
| Second Line Capital, LLC | 0 | $0 | 0.00% | −63,027−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −51,790−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −44,529−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −36,986−100.0% | Sold out |
| Kestra Private Wealth Services, LLC | 0 | $0 | 0.00% | −35,208−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −32,297−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −23,109−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −23,100−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −21,447−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −20,898−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −14,935−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −13,294−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −11,553−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −10,995−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −10,782−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −10,239−100.0% | Sold out |
| Quadcap Wealth Management, LLC | 0 | $0 | 0.00% | −9,799−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −6,988−100.0% | Sold out |
| Koss-Olinger Consulting, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,889−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −820−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −516−100.0% | Sold out |
| Bayforest Capital Ltd | 0 | $0 | 0.00% | −262−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Halbert Hargrove Global Advisors, LLC | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Hughes Financial Services, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Creekmur Asset Management LLC | – | – | – | – | Not filed |
| Wolverine Trading, LLC | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |
| CIBC Bancorp USA Inc. | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| AllSquare Wealth Management LLC | – | – | – | – | Not filed |
| Optimum Investment Advisors | – | – | – | – | Not filed |